Elevance Health, Inc. (ELV) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	201.8B	199.1B	176.8B	171.3B	156.6B
Cost of Revenue	128.1B	148.2B	127.6B	124.3B	116.6B
Gross Profit	73.8B	50.9B	49.2B	47.0B	40.0B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	12.1B	—	—	—	—
General & Admin Expense	6.3B	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	54.2B	42.8B	40.4B	38.3B	31.5B
Total Operating Expenses	66.3B	42.8B	40.4B	38.3B	31.5B
Cost and Expenses	194.4B	191.0B	167.9B	162.6B	148.1B
Operating Income (EBIT)	7.5B	8.1B	8.9B	8.7B	8.5B
Non-Operating
Interest Income	704.0M	—	—	—	—
Interest Expense	1.1B	1.4B	1.2B	1.0B	851.0M
Net Interest Income	(433.0M)	(1.4B)	(1.2B)	(1.0B)	(851.0M)
Other Non-Op Income/Expense	(1.2B)	(1.4B)	(984.0M)	(1.0B)	(851.0M)
Non-Operating Income (excl Interest)	70.0M	—	(201.0M)	—	—
EBT (Pre-Tax Income)	6.3B	6.7B	7.9B	7.7B	7.6B
Income Tax Expense	1.1B	1.0B	1.9B	1.7B	1.7B
Bottom Line
Net Income	5.1B	5.7B	6.0B	6.0B	5.9B
Earnings from Cont. Ops	5.1B	5.7B	6.0B	6.0B	5.9B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	5.1B	5.7B	6.0B	6.0B	5.9B
Per Share
Basic EPS	$23.48	$25.18	$25.81	$25.38	$24.56
Diluted EPS	$23.45	$25.12	$25.68	$25.22	$24.28
Revenue Per Share	$927.53	$897.77	$759.28	$735.14	$652.48
Shares
Basic Shares Outstanding	217.6M	221.8M	232.9M	233.1M	240.0M
Diluted Shares Outstanding	217.6M	221.8M	232.9M	237.4M	242.8M
Profitability Metrics
EBITDA	8.9B	9.7B	10.5B	10.5B	10.1B
D&A	1.5B	1.5B	1.4B	1.7B	1.7B
EBIT	7.4B	8.1B	9.1B	8.7B	8.5B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026